New lens aims to sharpen sight after dual eye surgery

NCT ID NCT07441616

Not yet recruiting Symptom relief Sponsor: Universitair Ziekenhuis Brussel Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will test a new type of artificial lens, called the PureSee IOL, in 10 people who need surgery for both cataracts and a cornea condition called Fuchs dystrophy. The goal is to see if this lens helps patients see well at different distances and reduces their need for glasses after surgery. Researchers will measure vision sharpness, contrast sensitivity, and patient satisfaction over six months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: PureSee™ extended range of vision intraocular lens (IOL)
What this could lead to: If successful, this lens could help people who need both cataract and cornea surgery see better at multiple distances and rely less on glasses.
What could go wrong: This is a very small feasibility study with only 10 participants and no comparison group. The results may not apply to everyone, and the lens may not perform as hoped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CATARACT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cataract Fuchs' endothelial dystrophy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CATARACT FUCHS ENDOTHELIAL CORNEAL DYSTROPHY

Contacts and locations

Locations

University Hospital Leuven

Leuven, 3000, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.